Marush Overseas Plans Active Pharmaceuticals Ingredients in Uttarakhand

Marush Overseas Private Limited to establish a new Active Pharmaceuticals Ingredients (API) Manufacturing Unit in the Lodiwala Grant Pargana neighbourhood of the city of Haridwar in the state of Uttarakhand.

The project's objective is to manufacture ten brand-new API products, such as paracetamol, albendazole, atomoxetine, losartan potassium, zinc pyrrithione, glimeperide, rosuvastatin calcium, sitagliptin phosphate monohydrate, ziprasidone, and olmesartan medoxomil, together with their respective intermediates on a campaign-by-campaign basis. It is anticipated that the project would have a total production capacity of 1,450 MT per Month. The total cost of the project was 53.45 Crore.

The total land area is 14,240 sq.mt. There are a total of 10 products, The capacity of production is 1450 MT per month.

Paracetamol, Albendazole, Atomoxetine, Losartan Potassium, Zinc Pyrithione, Glimeperide, Rosuvastatin Calcium, Sitagliptin phosphate monohydrate, Ziprasidone, and Olmesartan Medoxomil are some of the products that we carry.

The Features of the Project isTechnology for the manufacture of API that is cutting edge and very efficient, Facilities for quality assurance and control that are up to date. a scrupulous observance of all applicable environmental requirements.A dedication to environmentally responsible production methods.

As on November 2023, The project is now in the stage of construction being started. The completion of the project's work has reached the 70% mark. The work on the project will be finished by March of 2024.  

News by Rahul Yelligetti